Affordable Care Act (ACA) enrollment was stable in most places despite turmoil; National Institutes of Health research, opioid, and mental health funding see gains in budget deal, but ACA stabilization plan is missing.
Affordable Care Act (ACA) plan enrollment declined slightly, but states running their own marketplaces saw slight gains and did better than those relying on the federal exchange. About 11.8 million Americans enrolled in 2018 coverage, down 3.7% from last year’s total, according to the National Academy for State Health Policy, Kaiser Health News reported. The enrollment period was marked by a shorter time frame, a sharply reduced federal budget for outreach, and confusion during months of repeal-and-replace debate.
Funding for research at the National Institutes of Health would rise by $2 billion and spending to address opioid and mental health issues would rise by $6 billion over the next 2 years under a bipartisan budget agreement announced by Senate leaders, STAT reported. The White House endorsed the agreement and the House is also likely to pass it.
Last December, Senate Majority Leader Mitch McConnell, R-Kentucky, promised Senator Susan Collins, R-Maine, a vote on shoring up the ACA’s individual health insurance marketplaces in exchange for her vote for the GOP tax bill. So far, that vote has not materialized and is not included in the bipartisan budget agreement reached late Wednesday, Kaiser Health News reported. The deal does include most of the Democrats' other health priorities.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen